TGTX: TG Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 462.13
Enterprise Value ($M) 356.46
Book Value ($M) 101.38
Book Value / Share 1.22
Price / Book 4.56
NCAV ($M) 96.70
NCAV / Share 1.17
Price / NCAV 4.78

Profitability (mra)
Return on Invested Capital (ROIC) -1.77
Return on Assets (ROA) -2.16
Return on Equity (ROE) -3.30

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 3.68

Balance Sheet (mrq) ($M)
Current Assets 136.04
Assets 140.72
Liabilities 39.34
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -118.71
Net Income -118.48
Earnings Per Share Basic And Diluted -1.91

Cash Flow Statement (mra) ($M)
Cash From Operations -93.76
Cash from Investing -8.21
Cash from Financing -93.76

Source:
Fintel.io

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2018-07-11 13D/A LFB Biotechnologies S.A.S.U. 3.40 -65.66
2018-02-14 13G/A Bridger Management, Llc 6.20 -10.76
2018-02-13 13G/A FMR LLC / Fidelity 7.01 -23.26

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

File Date Form SEC Filings
2018-08-09 10-Q TGTX / TG Therapeutics, Inc. 10-Q (Quarterly Report)
2018-05-10 10-Q TGTX / TG Therapeutics, Inc. 10-Q (Quarterly Report)
2018-03-15 10-K TGTX / TG Therapeutics, Inc. 10-K (Annual Report)

Source:
Fintel.io

Similar Companies
TBRA – Tobira Therapeutics, Inc. TCON – TRACON Pharmaceuticals, Inc.
TECH – Bio-Techne Corp THLD – Threshold Pharmaceuticals, Inc.
THRX – Theravance, Inc.


Financial data and stock pages provided for FREE by
Fintel.io